Abstract
Development of an enzyme-linked immunosorbent assay, using a monoclonal antibody against a2-macroglobulin, for the diagnosis of systemic lupus erythematosus (HTML)
Cazzolla,Nicolas; Saso,Luciano; Grima,Josephine; Leone,Maria Grazia; Grippa,Eleanora; Cheng,Chuen-yan; Silvestrini,Bruno
Clinical Biochemistry 32(4): 249-255
Publication date: 1999
Objectives
To develop an enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody (mab) directed against abnormally glycosylated serum a-macroglobulin (a-M) from patients with systemic lupus erythematosus (SLE).
Design and methods
Serum a-M purified by HPLC from patients with SLE was injected in a Balb/c, CB6 F1 female mouse and hybrid cell lines were screened using a-M Glu-C fragments derived from SLE and normal donors (NHS). A mab was selected and used to develop an ELISA by which sera from NHS (n = 14), SLE (n = 34), rheumatoid arthritis (n = 15), Sjögren's syndrome (n = 11), mixed connective tissue diseases (n = 12), and liver diseases (n = 11) were analyzed.
Results
The affinity of the mab for a-M from SLE, but not from the other diseases, was higher compared to NHS, as demonstrated by immunoblotting and ELISA.
Conclusions
The ELISA was capable of recognizing changes of glycosylation of a-M in SLE and may be useful for its differential diagnosis.
What's New
For 60 years, the Population Council has changed the way the world thinks about important health and development issues. Explore an interactive timeline of the Council's history, learn more about some of our key contributions, and watch a short video about why your support is so important to us.
Get Involved
- Make a contribution to the Population Council
- Honor a loved one with a gift in his or her name
- Sign up to receive e-mail announcements








